North America’s medical devices industry saw a rise of 25.00% in cross border deal activity during March 2021, when compared with the last 12-month average, led by Organon &’s $240m acquisition of Alydia Health, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 20 medical devices industry cross border deals worth $919.51m were announced for the region in March 2021, against the 12-month average of 16 deals.

Of all the deal types, venture financing saw most activity in March 2021 with ten transactions, representing a 50% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was M&A with eight deals, followed by private equity deals with two transactions, respectively capturing a 40% and 10% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in North America’s medical devices industry with $488m, while venture financing and private equity deals totalled $310.51m and $121m, respectively.

North America medical devices industry cross border deals in March 2021: Top deals

The top five medical devices cross border deals accounted for 63.4% of the overall value during March 2021.

The combined value of the top five medical devices cross border deals stood at $583m, against the overall value of $919.51m recorded for the month.

The top five medical devices industry cross border deals of March 2021 tracked by GlobalData were:

1) Organon &’s $240m acquisition of Alydia Health

2) The $110m acquisition deal with 7D Surgical by SeaSpine

3) Alumni Ventures Group, aMoon Partners, Echo Health Ventures, Khosla Ventures and Northpond Ventures’ $82m venture financing of Scipher Medicine

4) The $81m private equity deal with Rapid Micro Biosystems by Adage Capital Management, Ally Bridge Group, Asahi Kasei Medical, Bain Capital Life Sciences, BlackRock, CaaS Capital Management, D1 Capital Partners, Endeavour Vision, Longitude Capital Management Co, Quaker Partners Management, Sunley House Capital Management, T Rowe Price Associates and Xeraya Capital Sdn

5) TELUS Health Solutions’ asset transaction with Babylon Healthcare Services for $70m.